ProMedica Bixby Hospital was a public hospital in Adrian, Michigan that is part of the ProMedica Health System. It was replaced in 2020 with Charles and Virginia Hickman Hospital. The new hospital also replaced Herrick Medical Center in Tecumseh.

There are 88 beds in Bixby Medical Center.

During the past decade, Bixby Medical Center conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 64 clinical trials were completed, i.e. on average, 1600% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 26 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bixby Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 51 trials, followed by "Alliance for Clinical Trials in Oncology" with 9 trials sponsored, "SWOG Cancer Research Network" with 9 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored and "Radiation Therapy Oncology Group" with 4 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bixby Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 32 trials as a collaborator, "NRG Oncology" with 11 trials as a collaborator, "NCIC Clinical Trials Group" with 7 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator and "SWOG Cancer Research Network" with 6 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Bixby Medical Center" are "Recurrent Breast Carcinoma" (7 trials), "Breast Cancer" (5 trials), "Clear Cell Renal Cell Carcinoma" (4 trials), "Stage IIA Breast Cancer AJCC v6 and v7" (4 trials) and "Stage IIB Breast Cancer AJCC v6 and v7" (4 trials). Many other conditions were trialed in "Bixby Medical Center" in a lesser frequency.

Most popular intervention types in "Bixby Medical Center" are "Drug" (76 trials), "Other" (54 trials), "Biological" (40 trials), "Radiation" (14 trials) and "Procedure" (7 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (43 trials), "Quality-of-Life Assessment" (19 trials), "Bevacizumab" (16 trials), "Paclitaxel" (11 trials) and "Carboplatin" (9 trials). Other intervention names were less common.

The vast majority of trials in "Bixby Medical Center" are 64 trials for "All" genders, 15 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Bixby Medical Center". undefined are not yet recruiting, 2 are recruiting, 38 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 31 completed trials in Bixby Medical Center, undefined suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Bixby Medical Center, 4 "Phase 1" clinical trials were conducted, 35 "Phase 2" clinical trials and 50 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".